Development and validation of a high throughput system for discovery of antigens for autoantibody detection.
An assay employing a panel of tumor-associated antigens has been validated and is available commercially (EarlyCDT®-Lung) to aid the early detection of lung cancer by measurement of serum autoantibodies. The high throughput (HTP) strategy described herein was pursued to identify new antigens to add...
Guardado en:
Autores principales: | Isabel K Macdonald, Jared Allen, Andrea Murray, Celine B Parsy-Kowalska, Graham F Healey, Caroline J Chapman, Herbert F Sewell, John F R Robertson |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2012
|
Materias: | |
Acceso en línea: | https://doaj.org/article/30b6bdc9b68c4fcf9e3b714380df206a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Application of a high throughput method of biomarker discovery to improvement of the EarlyCDT(®)-Lung Test.
por: Isabel K Macdonald, et al.
Publicado: (2012) -
A droplet microfluidic platform for high-throughput photochemical reaction discovery
por: Alexandra C. Sun, et al.
Publicado: (2020) -
AUTOANTIBODIES TO CIRTULLINATED ANTIGENS FOR DIAGNOSIS AND PREDICTION OF CLINICAL COURSE IN EARLY RHEUMATOID ARTHRITIS
por: I. B. Belyaeva, et al.
Publicado: (2014) -
DRUG-seq for miniaturized high-throughput transcriptome profiling in drug discovery
por: Chaoyang Ye, et al.
Publicado: (2018) -
Antigen Discovery, Bioinformatics and Biological Characterization of Novel Immunodominant Babesia microti Antigens
por: Nitin Verma, et al.
Publicado: (2020)